Real-time Estimate Cboe Europe 10:38:25 2024-07-15 am EDT 5-day change 1st Jan Change
81.23 CHF -0.60% Intraday chart for Alcon Inc. +1.22% +24.28%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Morgan Stanley Upgrades Alcon to Equalweight From Underweight, Raises Price Target to $85 From $65 MT
Berenberg Lifts Price Target on Alcon, Maintains Buy Recommendation MT
Berenberg Raises Price Target on Alcon to CHF93 From CHF90, Cites Optimism for Second Half, Keeps Buy Rating MT
Alcon Completes Acquisition of Ophthalmic Laser Therapy Company Belkin Vision MT
Alcon Says Unity Vitreoretinal Cataract, Cataract Systems Get FDA Clearance MT
Alcon: two eye surgery systems approved in the USA CF
Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance CI
AlphaValue/Baader Europe Lowers Price Target on Alcon, Maintains Add Recommendation MT
Switzerland's Alcon Launches Middle East Headquarters in Saudi Arabia MT
UBS Lifts Alcon PT, Keeps Buy Recommendation MT
ALCON : UBS raises its target price CF
Moody’s Upgrades Alcon on Strong Financial Performance MT
Stifel Adjusts Price Target on Alcon to $100 From $95, Maintains Buy Rating MT
Oppenheimer Upgrades Alcon to Outperform From Perform, $103 Price Target MT
Baird Adjusts Price Target on Alcon to $104 From $95, Maintains Outperform Rating MT
Needham Adjusts Price Target on Alcon to $101 From $98, Keeps Buy Rating MT
Global markets live: Apple, Sony, Vodafone, Booking, Walmart... Our Logo
ALCON : Markets rejoice at the Q1 beat; guidance upgraded Alphavalue
Transcript : Alcon Inc., Q1 2024 Earnings Call, May 14, 2024
Alcon: surrounded after its quarterly results CF
Alcon's Swiss Shares Jump After Contact-Lense Sales Boost Earnings DJ
European shares muted ahead of US inflation, Powell remarks; Delivery Hero spikes RE
Alcon Posts Higher Q1 Net Income, Net Sales MT
Alcon Q1 Core Earnings, Sales Rise; 2024 Outlook Reaffirmed MT
Earnings Flash (ALC) ALCON Posts Q1 EPS $0.78 MT
Chart Alcon Inc.
More charts
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
91.38 USD
Average target price
93.95 USD
Spread / Average Target
+2.81%
Consensus
  1. Stock Market
  2. Equities
  3. ALC Stock
  4. News Alcon Inc.
  5. Switzerland's Alcon Launches Middle East Headquarters in Saudi Arabia